| Literature DB >> 12552586 |
John A Heddle1, Hans-Joerg Martus, George R Douglas.
Abstract
The standard protocol for testing chemicals with the transgenic mutation assays in vivo includes a period of time between treatment and sampling to permit the mutation frequency to reach a maximum. Recent evidence has shown, however, that for some chemicals the mutant frequency can decline substantially during this period, which would reduce the sensitivity of the assay. Here we discuss alternate protocols to maintain the sensitivity of the assay for both types of mutagens and, in particular, propose that treatments should continue until the time of sampling. Copyright 2003 Wiley-Liss, Inc.Mesh:
Year: 2003 PMID: 12552586 DOI: 10.1002/em.10131
Source DB: PubMed Journal: Environ Mol Mutagen ISSN: 0893-6692 Impact factor: 3.216